Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,069Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2PF PRISM CV

02 13PFIZER

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3326

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3326

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3328

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3328

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3329

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : 11253523

Drug Substance Claim :

Drug Product Claim :

Application Number : 208246

Patent Use Code : U-3329

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : RE41783

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 203214

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-08

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOFACITINIB CITRATE

US Patent Number : RE41783

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 208246

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-08

blank